BG
Bellevue Group Portfolio holdings
AUM
$4.54B
1-Year Return
22.5%
This Quarter Return
-16.23%
1 Year Return
+22.5%
3 Year Return
+98.22%
5 Year Return
+159.37%
10 Year Return
–
AUM
$1.45B
AUM Growth
-$125M
(-8%)
Cap. Flow
+$148M
Cap. Flow
% of AUM
10.17%
Top 10 Holdings %
Top 10 Hldgs %
37.98%
Holding
149
New
10
Increased
70
Reduced
43
Closed
11
Top Buys
| 1 |
Align Technology
ALGN
|
$34.4M |
| 2 |
Illumina
ILMN
|
$31.2M |
| 3 |
Intuitive Surgical
ISRG
|
$24.4M |
| 4 |
Teladoc Health
TDOC
|
$24.2M |
| 5 |
Abbott
ABT
|
$15.2M |
Top Sells
| 1 |
KTWO
K2M Group Holdings, Inc
KTWO
|
$15.1M |
| 2 |
Centene
CNC
|
$14.7M |
| 3 |
Edwards Lifesciences
EW
|
$14.6M |
| 4 |
Pacific Biosciences
PACB
|
$13.9M |
| 5 |
SHPG
Shire pic
SHPG
|
$11.6M |
Sector Composition
| 1 | Healthcare | 92.41% |
| 2 | Industrials | 1.04% |
| 3 | Technology | 0.54% |
| 4 | Financials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Biogen
BIIB
$20.9B
| $7.6M | 0.5% |
25,250
-13,995
| -36% | -$4.21M |
|
52
Cooper Companies
COO
$13.7B
| $7.54M | 0.5% |
118,476
+27,232
| +30% | +$1.73M |
|
|
XENT
53
DELISTED
Intersect ENT, Inc
XENT
| $6.69M | 0.44% |
237,444
+3,217
| +1% | +$90.7K |
|
54
Globus Medical
GMED
$8.17B
| $6.62M | 0.44% |
153,031
+1,780
| +1% | +$77K |
|
55
Omnicell
OMCL
$1.52B
| $6.62M | 0.44% |
108,042
+3,392
| +3% | +$208K |
|
56
Integra LifeSciences
IART
$1.25B
| $6.58M | 0.43% |
145,779
+4,159
| +3% | +$188K |
|
57
Molina Healthcare
MOH
$9.37B
| $6.44M | 0.42% |
55,384
+4,906
| +10% | +$570K |
|
58
ResMed
RMD
$40.4B
| $6.31M | 0.41% |
55,392
-37,800
| -41% | -$4.3M |
|
59
QuidelOrtho
QDEL
$1.95B
| $6.1M | 0.4% |
+125,000
| New | +$6.1M |
|
|
HMSY
60
DELISTED
HMS Holdings Corp.
HMSY
| $6.1M | 0.4% |
216,817
-10,203
| -4% | -$287K |
|
61
HCA Healthcare
HCA
$97B
| $5.85M | 0.38% |
47,034
+10,146
| +28% | +$1.26M |
|
62
iRhythm Technologies
IRTC
$5.91B
| $5.82M | 0.38% |
83,792
+14,131
| +20% | +$982K |
|
63
Regeneron Pharmaceuticals
REGN
$60.3B
| $5.68M | 0.37% |
15,200
-10,280
| -40% | -$3.84M |
|
|
TRHC
64
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
| $5.6M | 0.37% |
87,857
+973
| +1% | +$62K |
|
65
Viatris
VTRS
$12.2B
| $5.4M | 0.35% |
196,950
-368,400
| -65% | -$10.1M |
|
66
Quanterix
QTRX
$209M
| $5.24M | 0.34% |
285,907
-27,323
| -9% | -$500K |
|
67
Teleflex
TFX
$5.79B
| $5.1M | 0.34% |
19,748
+1,956
| +11% | +$506K |
|
|
QTNT
68
DELISTED
Quotient Limited Ordinary Shares
QTNT
| $5.1M | 0.34% |
20,840
+2,794
| +15% | +$684K |
|
69
Idexx Laboratories
IDXX
$51.7B
| $4.52M | 0.3% |
24,307
| – | – |
|
|
MTLS
70
Materialise
MTLS
$296M
| $4.31M | 0.28% |
215,192
+4,461
| +2% | +$89.3K |
|
71
Inogen
INGN
$224M
| $4.13M | 0.27% |
33,292
+10,031
| +43% | +$1.25M |
|
72
Dentsply Sirona
XRAY
$2.92B
| $4.13M | 0.27% |
110,878
| – | – |
|
73
Guardant Health
GH
$7.44B
| $4.1M | 0.27% |
+109,117
| New | +$4.1M |
|
74
Henry Schein
HSIC
$8.32B
| $4.03M | 0.27% |
65,494
| – | – |
|
|
OXFD
75
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $3.92M | 0.26% |
306,606
+84,769
| +38% | +$1.08M |
|